172 related articles for article (PubMed ID: 16112174)
1. Patient-provider communication and perceived control for women experiencing multiple symptoms associated with ovarian cancer.
Donovan HS; Hartenbach EM; Method MW
Gynecol Oncol; 2005 Nov; 99(2):404-11. PubMed ID: 16112174
[TBL] [Abstract][Full Text] [Related]
2. Canadian women's perspectives on ovarian cancer.
Fitch MI; Gray RE; DePetrillo D; Franssen E; Howell D
Cancer Prev Control; 1999 Feb; 3(1):52-60. PubMed ID: 10474753
[TBL] [Abstract][Full Text] [Related]
3. Representations of fatigue in women receiving chemotherapy for gynecologic cancers.
Donovan HS; Ward S
Oncol Nurs Forum; 2005 Jan; 32(1):113-6. PubMed ID: 15660150
[TBL] [Abstract][Full Text] [Related]
4. Predictors of self-reported memory problems in patients with ovarian cancer who have received chemotherapy.
Myers JS; Sousa VD; Donovan HS
Oncol Nurs Forum; 2010 Sep; 37(5):596-603. PubMed ID: 20797951
[TBL] [Abstract][Full Text] [Related]
5. A study of symptoms described by ovarian cancer survivors.
Stavraka C; Ford A; Ghaem-Maghami S; Crook T; Agarwal R; Gabra H; Blagden S
Gynecol Oncol; 2012 Apr; 125(1):59-64. PubMed ID: 22155797
[TBL] [Abstract][Full Text] [Related]
6. Cancer and treatment-related symptoms are associated with mobility disability in women with ovarian cancer: A cross-sectional study.
Campbell G; Hagan T; Gilbertson-White S; Houze M; Donovan H
Gynecol Oncol; 2016 Dec; 143(3):578-583. PubMed ID: 27653982
[TBL] [Abstract][Full Text] [Related]
7. OVQUEST - Life after the diagnosis and treatment of ovarian cancer - An international survey of symptoms and concerns in ovarian cancer survivors.
Webber K; Carolus E; Mileshkin L; Sommeijer D; McAlpine J; Bladgen S; Coleman RL; Herzog TJ; Sehouli J; Nasser S; Inci G; Friedlander M
Gynecol Oncol; 2019 Oct; 155(1):126-134. PubMed ID: 31416612
[TBL] [Abstract][Full Text] [Related]
8. Symptom management in women with recurrent ovarian cancer: Do patients and clinicians agree on what symptoms are most important?
Hay CM; Courtney-Brooks M; Lefkowits C; Hagan TL; Edwards RP; Donovan HS
Gynecol Oncol; 2016 Nov; 143(2):367-370. PubMed ID: 27531571
[TBL] [Abstract][Full Text] [Related]
9. Creating Individualized Symptom Management Goals and Strategies for Cancer-Related Fatigue for Patients With Recurrent Ovarian Cancer.
Hagan TL; Arida JA; Hughes SH; Donovan HS
Cancer Nurs; 2017; 40(4):305-313. PubMed ID: 27333127
[TBL] [Abstract][Full Text] [Related]
10. Linkages among empathic behaviors, physical symptoms, and psychological distress in patients with ovarian cancer: a pilot study.
Lobchuk MM; Bokhari SA
Oncol Nurs Forum; 2008 Sep; 35(5):808-14. PubMed ID: 18765327
[TBL] [Abstract][Full Text] [Related]
11. Perceived patient-centered communication, quality of life, and symptom burden in individuals with ovarian cancer.
Pozzar RA; Xiong N; Hong F; Wright AA; Goff BA; Underhill-Blazey ML; Tulsky JA; Hammer MJ; Berry DL
Gynecol Oncol; 2021 Nov; 163(2):408-418. PubMed ID: 34454724
[TBL] [Abstract][Full Text] [Related]
12. Predictors of adjustment and growth in women with recurrent ovarian cancer.
Ponto JA; Ellington L; Mellon S; Beck SL
Oncol Nurs Forum; 2010 May; 37(3):357-64. PubMed ID: 20439220
[TBL] [Abstract][Full Text] [Related]
13. Symptoms attributed to ovarian cancer by women with the disease.
Igoe BA
Nurse Pract; 1997 Jul; 22(7):122, 127-8, 130 passim. PubMed ID: 9253020
[TBL] [Abstract][Full Text] [Related]
14. Differences between women who pursued genetic testing for hereditary breast and ovarian cancer and their at-risk relatives who did not.
Katapodi MC; Northouse L; Pierce P; Milliron KJ; Liu G; Merajver SD
Oncol Nurs Forum; 2011 Sep; 38(5):572-81. PubMed ID: 21875844
[TBL] [Abstract][Full Text] [Related]
15. Hopelessness and complementary therapy use in patients with ovarian cancer.
Gross AH; Cromwell J; Fonteyn M; Matulonis UA; Hayman LL
Cancer Nurs; 2013; 36(4):256-64. PubMed ID: 23086133
[TBL] [Abstract][Full Text] [Related]
16. Gaps in communication between cancer patients and healthcare providers: symptom distress and patients' intentions to disclose.
Penalba V; Deshields TL; Klinkenberg D
Support Care Cancer; 2019 Jun; 27(6):2039-2047. PubMed ID: 30220028
[TBL] [Abstract][Full Text] [Related]
17. Ovarian cancer survivors' acceptance of treatment side effects evolves as goals of care change over the cancer continuum.
Frey MK; Ellis AE; Koontz LM; Shyne S; Klingenberg B; Fields JC; Chern JY; Blank SV
Gynecol Oncol; 2017 Aug; 146(2):386-391. PubMed ID: 28602549
[TBL] [Abstract][Full Text] [Related]
18. Transforming the death sentence: elements of hope in women with advanced ovarian cancer.
Reb AM
Oncol Nurs Forum; 2007 Nov; 34(6):E70-81. PubMed ID: 18024333
[TBL] [Abstract][Full Text] [Related]
19. Symptom clustering and quality of life in patients with ovarian cancer undergoing chemotherapy.
Nho JH; Reul Kim S; Nam JH
Eur J Oncol Nurs; 2017 Oct; 30():8-14. PubMed ID: 29031318
[TBL] [Abstract][Full Text] [Related]
20. Coping With Pain Severity, Distress, and Consequences in Women With Ovarian Cancer.
Gilbertson-White S; Campbell G; Ward S; Sherwood P; Donovan H
Cancer Nurs; 2017; 40(2):117-123. PubMed ID: 27088608
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
